Marketing of the life sciences: A new framework and research agenda for a nascent field

S Stremersch, W Van Dyck - Journal of Marketing, 2009 - journals.sagepub.com
Although marketing scholars often seek to contribute new knowledge that is applicable
across industries, some industries have unique characteristics that require industry-specific …

Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry

CH Song, JW Han - SpringerPlus, 2016 - Springer
Extending the period of the market exclusivity and responding properly to the recent
agglomeration of patent expiries are pivotal to the success of pharmaceutical companies …

Innovation in the pharmaceutical industry: The process of drug discovery and development

E Petrova - Innovation and Marketing in the Pharmaceutical …, 2013 - Springer
Continuous innovation is one of the pharmaceutical industry's most defining characteristics.
New medications can be crucial for maintaining the quality of human life, and may even …

Competition in off-patent drug markets: Issues, regulation and evidence

P Kanavos, J Costa-Font, E Seeley - Economic policy, 2008 - academic.oup.com
In recent years health insurers have placed a great deal of emphasis on the ability of generic
medicines to deliver significant savings to overstretched health care budgets due to their …

PARALLEL TRADE, INTERNATIONAL EXHAUSTION AND INTELLECTUAL PROPERTY RIGHTS: A WELFARE ANALYSIS*

TM Valletti, S Szymanski - The Journal of Industrial Economics, 2006 - Wiley Online Library
This paper analyses the issue of parallel trade (arbitrage) for products protected by
intellectual property rights. We discuss a basic trade‐off that arises between the ex post …

Identifying and prioritizing industry-level competitiveness factors: evidence from pharmaceutical market

H Shabaninejad, G Mehralian, A Rashidian… - DARU journal of …, 2014 - Springer
Background Pharmaceutical industry is knowledge-intensive and highly globalized, in both
developed and developing countries. On the other hand, if companies want to survive, they …

Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies

J Kersnik, J Peklar - Journal of clinical pharmacy and …, 2006 - Wiley Online Library
Background: Over the recent years there has been a steady 7% yearly increase in
prescribing costs, which accounts for 17% of the Slovene national health care budget …

Factors associated with drug shortages in Canada: a retrospective cohort study

W Zhang, DP Guh, H Sun, LD Lynd, A Hollis… - … Open Access Journal, 2020 - cmajopen.ca
Background: To monitor the magnitude of the drug shortage problem in Canada, since 2017,
Health Canada has required manufacturers to report drug shortages. This study aimed to …

The anti-competitive effects of brand-controlled" pseudo-generics" in the Canadian pharmaceutical market

A Hollis - Canadian Public Policy/Analyse de Politiques, 2003 - JSTOR
Brand-name pharmaceutical firms in Canada, upon the expiry of their patent, always license
a" pseudogeneric" firm to compete directly against generic firms. This pseudo-generic is …

Generic entry into the regulated Spanish pharmaceutical market

I Moreno-Torres, J Puig-Junoy, JR Borrell - Review of Industrial …, 2009 - Springer
This paper empirically analyses entry by generic firms into the strictly regulated Spanish
pharmaceutical market. We estimate a fixed effects negative binomial entry model using a …